Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amal Shibli-Rahhal

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Endocrinology and Metabolism Clinics of North America|November 24, 2011
Hyperprolactinemia and infertilityAmal Shibli-Rahhal, Janet Schlechte
Eating and Weight Disorders : EWD|June 14, 2013
Teriparatide treatment of osteoporosis in a patient with anorexia nervosaAmal Shibli-Rahhal, Laurie McCormick
Patient Education and Counseling|July 10, 2021
Development and evaluation of novel tool to assess communication skills in adult triadic interviewsAmal Shibli-Rahhal, Clarence Kreiter
Journal of Bone Metabolism|September 27, 2019
Anorexia Nervosa and Osteoporosis: Pathophysiology and TreatmentJeremy Steinman, Amal Shibli-Rahhal
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 11, 2022
Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the LiteratureChermaine Hung, Amal Shibli-Rahhal
Pituitary|March 14, 2008
The effects of hyperprolactinemia on bone and fatAmal Shibli-Rahhal, Janet Schlechte
Journal of Bone Metabolism|March 18, 2021
Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 YearTarun Kadaru, Amal Shibli-Rahhal
Muscle & Nerve|July 10, 2013
Bone density and alendronate effects in Duchenne muscular dystrophy patientsCaroline Houston, Katherine Mathews, Amal Shibli-Rahhal
Clinical Obstetrics and Gynecology|October 5, 2020
Bone Health and Osteoporosis Prevention and TreatmentMarcus Muñoz, Kathleen Robinson, Amal Shibli-Rahhal
Calcified Tissue International|March 5, 2021
Anorexia Nervosa and OsteoporosisChermaine Hung, Marcus Muñoz, Amal Shibli-Rahhal
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Endocrinology and Metabolism Clinics of North America|November 24, 2011
Hyperprolactinemia and infertilityAmal Shibli-Rahhal, Janet Schlechte
Eating and Weight Disorders : EWD|June 14, 2013
Teriparatide treatment of osteoporosis in a patient with anorexia nervosaAmal Shibli-Rahhal, Laurie McCormick
Patient Education and Counseling|July 10, 2021
Development and evaluation of novel tool to assess communication skills in adult triadic interviewsAmal Shibli-Rahhal, Clarence Kreiter
Journal of Bone Metabolism|September 27, 2019
Anorexia Nervosa and Osteoporosis: Pathophysiology and TreatmentJeremy Steinman, Amal Shibli-Rahhal
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 11, 2022
Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the LiteratureChermaine Hung, Amal Shibli-Rahhal
Pituitary|March 14, 2008
The effects of hyperprolactinemia on bone and fatAmal Shibli-Rahhal, Janet Schlechte
Journal of Bone Metabolism|March 18, 2021
Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 YearTarun Kadaru, Amal Shibli-Rahhal
Muscle & Nerve|July 10, 2013
Bone density and alendronate effects in Duchenne muscular dystrophy patientsCaroline Houston, Katherine Mathews, Amal Shibli-Rahhal
Clinical Obstetrics and Gynecology|October 5, 2020
Bone Health and Osteoporosis Prevention and TreatmentMarcus Muñoz, Kathleen Robinson, Amal Shibli-Rahhal
Calcified Tissue International|March 5, 2021
Anorexia Nervosa and OsteoporosisChermaine Hung, Marcus Muñoz, Amal Shibli-Rahhal
Pageof 3